Cargando…

Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter Pylori Infection

BACKGROUND/AIMS: Treatment success for Helicobacter pylori infection in Saudi Arabia is relatively unexplored. This prospective study compared the efficacy of sequential versus standard triple therapy in curing H. pylori infections. PATIENTS AND METHODS: Eligible patients underwent upper endoscopy a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsohaibani, Fahad, Al Ashgar, Hamad, Al Kahtani, Khalid, Kagevi, Ingvar, Peedikayil, Musthafa, Alfadda, Abdulrahman, Khan, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542420/ https://www.ncbi.nlm.nih.gov/pubmed/26228365 http://dx.doi.org/10.4103/1319-3767.161647

Ejemplares similares

Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
por: Alsohaibani, Fahad, et al.
Publicado: (2020)

Response to: Treatment Prolongation or Quadruple Therapy:- Individualization by Geographical Region
por: Alsohaibani, Fahad, et al.
Publicado: (2016)

Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials
por: Peedikayil, Musthafa Chalikandy, et al.
Publicado: (2014)

The cost-effectiveness of sequential versus standard triple therapy for Helicobacter pylori eradication in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients
por: Al Fadda, Mohammed, et al.
Publicado: (2012)

Wilson disease in 71 patients followed for over two decades in a tertiary center in Saudi Arabia: a retrospective review
por: Al Fadda, Mohammed, et al.
Publicado: (2012)

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
por: Liou, Jyh-Ming, et al.
Publicado: (2016)

A Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter pylori Infection: A Further Confirmation of “Geographic Weight”
por: Losurdo, Giuseppe, et al.
Publicado: (2016)

Tenofovir in the Treatment of Naïve and Refractory Chronic Hepatitis B: A Single Center Experience in Saudi Arabia
por: Alsohaibani, Fahad, et al.
Publicado: (2015)

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy
por: Chiu, Yu‐Tse, et al.
Publicado: (2023)

Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea
por: Kim, Beom Jin, et al.
Publicado: (2019)

Defecation of a “colon cast” as a rare presentation of acute graft-versus-host disease
por: Al Ashgar, Hamad, et al.
Publicado: (2009)

Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Hajiani, Eskandar, et al.
Publicado: (2018)

Clinical Significance of Numerous Irregular Polypoidal Lesions in the Duodenum
por: Helmy, Ahmed, et al.
Publicado: (2010)

HBsAg clearance in chronic hepatitis B patients with add-on pegylated interferon alfa-2a to ongoing tenofovir treatment: A randomized controlled study
por: Al Ashgar, Hamad, et al.
Publicado: (2017)

Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia
por: Chan, Chung-Chuan, et al.
Publicado: (2015)

Diagnostic Utility of Impedance-pH Monitoring in Refractory Non-erosive Reflux Disease
por: Khan, Mohammed Q, et al.
Publicado: (2014)

Sustained Virologic Response to Peginterferon α-2a and Ribavirin in 335 Patients with Chronic Hepatitis C: A Tertiary Care Center Experience
por: Al Ashgar, Hamad, et al.
Publicado: (2008)

Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
por: Lee, Seong tae, et al.
Publicado: (2015)

Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia
por: AlWabel, Ahmed H, et al.
Publicado: (2022)

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
por: Tai, Wei-Chen, et al.
Publicado: (2013)

Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district
por: Shah, Syed Fahim, et al.
Publicado: (2022)

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
por: Chang, Ji Young, et al.
Publicado: (2017)

Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Helicobacter pylori Eradication
por: Park, Chan Hyuk, et al.
Publicado: (2022)

Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
por: Lee, Hyuk, et al.
Publicado: (2017)

Seven-day genotypic resistance-guided triple Helicobacter pylori eradication therapy can be highly effective
por: Papastergiou, Vasilios, et al.
Publicado: (2018)

Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients
por: Arama, Stefan Sorin, et al.
Publicado: (2016)

Entecavir for the treatment of real-life chronic hepatitis B patients: a study from Saudi Arabia
por: Al-Ashqar, Hamad Ibrahim, et al.
Publicado: (2013)

Leukocyte Apheresis in the Management of Ulcerative Colitis
por: Helmy, Ahmed, et al.
Publicado: (2009)

Correction to: Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
por: Lee, Hyuk, et al.
Publicado: (2017)

Metastatic hepatic carcinoid associated with ectopic ACTH syndrome, resistant to octreotide and ketoconazole therapy
por: Khan, Mohammed Qassim, et al.
Publicado: (2004)

Addition of clidinium-C to the 14-day proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016)

Randomized Clinical Trial on the Efficacy of Triple Therapy Versus Sequential Therapy in Helicobacter pylori Eradication
por: Sharif, Zain, et al.
Publicado: (2022)

Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial
por: Elkhodary, Noha Mahmoud, et al.
Publicado: (2020)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
por: Azab, Eman T., et al.
Publicado: (2022)

Resolution of refractory hepatic hydrothorax in patients with hepatitis C virus cirrhosis after treatment with direct-acting antiviral agents
por: Hussein, Maged H., et al.
Publicado: (2018)

Do Probiotics Improve Eradication Response to Helicobacter Pylori on Standard Triple or Sequential Therapy?
por: Dajani, Asad I., et al.
Publicado: (2013)

Response to: Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2016)

Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication of Helicobacter pylori Infection
por: Chen, Ming-Cheh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kceo6ejmjk6hbcojske6oe2quh